Stock search

Ticker or company name

DaVita

DVA · NYSE · Health Care

$174,22Down −0,34 (−0,19%)today

Quotes delayed up to 15 min. Updated 16 Nov, 16:00 New York time

Market cap
$11,0 bn
Div. yield
—
Year to date
+53,2%
52 weeks: $101,00$247,49

Ratio score

72/100
Ratio would consider buying

based on 9 metrics as of 16.11.2026 ·

Verdict by our methodology based on current metrics. Not an investment recommendation.

Key metrics

5 ✓ · 3 — · 1 ✕ · 1 n/a · hover over a row or tap it to see the trend

All metrics

MetricValue5-year medianIndustry median
P/E TTM11,913,125,1
Forward P/E11,8—16,2
PEG0,4—2,2
P/S0,80,82,2
EV/EBITDA7,67,617,3
P/FCF8,5—19,5
P/B90,79,83,4

Industry median — across 33 profitable companies in “Health Care” in Ratio. Revenue and EPS forecasts for future years and the number of employees are in the paid data plan.

Price chart

Compare with

Choose a stock

Closing prices adjusted for splits and dividends. The S&P 500 index and the intraday chart come later.

Analysts

Ratings, 13 analysts

Buy
7
Hold
5
Sell
1

Beat the EPS forecast in 3 of the last 4 quarters

QuarterEstimateActualSurprise
Q3 20263,643,40Down −6,6%
Q2 20263,924,02Up +2,5%
Q1 20262,342,87Up +22,6%
Q4 20253,193,40Up +6,7%

Price targets and yearly revenue and EPS forecasts are in the paid data plan. These are analysts' opinions, not our verdict.

Financials in charts

MetricQ3'26Q2'26Q1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23
Revenue3,58 bn3,55 bn3,42 bn3,62 bn3,42 bn3,38 bn3,22 bn3,29 bn3,26 bn3,19 bn3,07 bn3,15 bn
EPS3,404,022,873,222,042,582,003,072,502,502,651,62
Margin6,2%7,5%5,8%6,5%4,4%5,9%5,1%7,9%6,6%7,0%7,8%4,8%
FCF359 m320 m219 m395 m675 m203 m36,8 m377 m671 m674 m−256 m326 m

From SEC reports. TTM is the sum of 4 quarters; a year is TTM at the end of the calendar year. Forecast bars are in the paid data plan.

Owners

Ownership structure and major holders (13F filings) are in the paid data plan. They are not part of the score or the traffic light.

Insider trades over 12 months

Over 12 months: no purchases, sales $523 m.

NameAmountSharesPrice
berkshire hathaway inc27 Oct 2026 · sale$69,0 m382 563$180,43
berkshire hathaway inc31 Jul 2026 · sale$36,5 m182 980$199,55
rodriguez javier16 Jun 2026 · sale$8,25 m39 407$209,28
waters kathleen alyce15 Jun 2026 · sale$1,35 m6 455$209,17
waters kathleen alyce15 Jun 2026 · sale$1,86 m8 950$207,84
rodriguez javier15 Jun 2026 · sale$6,29 m30 000$209,50
hearty james o15 May 2026 · sale$2,91 m15 000$193,98
maughan david paul12 May 2026 · sale$2,68 m13 456$199,25
maughan david paul11 May 2026 · sale$1,41 m7 073$199,15
ackerman joel7 May 2026 · sale$9,89 m51 471$192,10
hearty james o6 May 2026 · sale$381 9162 184$174,87
buffett warren e1 May 2026 · sale$183 m1 220 376$149,84
buffett warren e29 Jan 2026 · sale$200 m1 658 480$120,56

SEC Form 4. Titles and trading plans are not in the data. They are not part of the score or the traffic light.

About the company

Industry
Health Care
Exchange
NYSE
Country
US
IPO date
31 Oct 1995

Company description, revenue by segment and region, and the CEO will come later.

Next report
date not announced

An AI summary of the earnings call will come later.

Peers

CompanyPrice
UHSUniversal Health Services$197,8078would consider7,8+8,0%8,0%
PODDInsulet Corporation$145,2989would consider24,7+26,5%13,4%
ALGNAlign Technology$165,9889would consider24,1+4,4%11,8%
COOCooper Companies (The)$61,8889would consider20,9+4,7%13,5%
HSICHenry Schein$84,9683would consider22,6+6,2%3,1%
Compare with peers

Ratio — a score by our methodology, not an investment recommendation.